SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-137265
Filing Date
2023-05-05
Accepted
2023-05-05 17:29:10
Documents
5
Effectiveness Date
2023-05-05

Document Format Files

Seq Description Document Type Size
1 S-8 d356174ds8.htm S-8 40129
2 EX-5.1 d356174dex51.htm EX-5.1 6708
3 EX-23.1 d356174dex231.htm EX-23.1 2013
4 EX-FILING FEES d356174dexfilingfees.htm EX-FILING FEES 14753
5 GRAPHIC g356174g0505032223860.jpg GRAPHIC 2495
  Complete submission text file 0001193125-23-137265.txt   68185
Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271704 | Film No.: 23895139
SIC: 2834 Pharmaceutical Preparations